SRSF2 regulation of MDM2 reveals splicing as a therapeutic vulnerability of the p53 pathway
D. F. Comiskey, M. Montes, S. Khurshid, R. K. Singh, D. S. Chandler
This study shows that SRSF2 regulates MDM2 splicing, affecting p53 activity, and suggests splicing modulation as a potential therapeutic strategy for cancer.
bioRxiv · Sep 26, 2019Cancer Biology